<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01998243</url>
  </required_header>
  <id_info>
    <org_study_id>fis PI070682</org_study_id>
    <secondary_id>FIS PI070682</secondary_id>
    <nct_id>NCT01998243</nct_id>
  </id_info>
  <brief_title>Usefulness and Safeness Of Intra-Gastric Balloon Before Bariatric Surgery In Morbid Obesity</brief_title>
  <official_title>Usefulness Of Intra-Gastric Balloon Before Bariatric Surgery In Morbid Obesity To Decrease Bariatric Surgery Morbidity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Severo Ochoa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Severo Ochoa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: bariatric surgery shows an important morbidity and there are some reports that
      have used preoperative intragastric-balloons (IGB-BIB®) to decrease surgical morbidity.

      Patients Methods: Since 2009 we are performing a randomized and prospective study to assess
      the usefulness of (IGB-BIB®) before bariatric surgery [sleeve resection (SR) or gastric
      bypass (GB)] &quot;group A&quot;. The intervention in this group was was to place an intragastric
      Balloon for 6 months vs a control group &quot;B&quot; with the same type of surgical procedures but
      without preoperative IGB-BIB.The intervention on this group was only to treat the obesity
      only with diet for 6 months . All patients coming for both groups were followed at 4-week
      intervals by a nurse practitioner and dietitian for 6 months, Nurse practitioner made the
      dietetics adjustments (750-1500 Kcal) , provide advice and assess the evolution of weight
      loss The hypothesis was that preoperative IGB-BIB helps the patients to lose weight ( more
      than 10%) ,and the weight loss will contribute to decrease surgical morbidity by at least
      30%, and also will decrease hospital stay Objective: to check if morbidity, mortality and
      hospital stay decreased in the IGB-BIB ® group, and secondly if the weight before surgery was
      associated with surgical morbidity. secondary objective : Assess the rate of IGB-BIB
      failure.Intragastric balloon failure was considered when the weight loss is less than 10%
      from the initial weight. We defined severe complication whenever the patient had to be
      admitted in the hospital after discharge, new surgeries or transfusions were required or the
      hospital stay was longer than 7-10 days.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Treatment with an intragastric balloon (IGB) for morbid obesity is a temporary treatment
      reached as a second step, when the initial nutritional multidisciplinary approach has failed;
      however, its value is not clear compared with other conventional medical treatments ], though
      some authors have stated that IGB achieves higher weight loss than conventional diet
      treatments (12.2% of the initial weight) ]; and others have positioned IGB as the first valid
      step in order to achieve weight loss in patients who are adequate for a future gastric bypass
      surgery. Genco et al (2009) have compared the treatment with IGB only vs. laparoscopic sleeve
      gastrectomy (LSG), and have found no differences in the amount of weight loss at 6 months,
      but a reduction in adverse events caused by IGB treatment.

      One of the potential future indications for the intragastric balloon could be its use as a
      bridge-treatment until bariatric surgery, not only in order to achieve weight loss before
      surgery, but also to select the group of patients who might benefit more from derivative
      surgery, as suggested by some authors or its use in special populations such as super-obese
      patients . The objective would be to reduce weight before the surgical procedure, in order to
      improve comorbidities, facilitate the surgical technique, and potentially reduce any surgical
      complications.

      It is increasingly frequent in many surgical units to try and achieve weigh loss before
      bariatric surgery, using intragastric balloons (IGB). However, this therapeutic approach
      currently presents dubious utility. Our study intends to contribute with our experience in
      the evaluation of IGB before surgery for achieving weight loss, and its impact on
      post-surgical morbidity.

      Bariatric surgery shows an important morbidity and there are not to many randomized
      prospective studies using intragastric- balloons (IGB-BIB®) to evaluate if getting weight
      lost really matter on decreasing surgical complications before Bariatric surgery OBJECTIVE:
      To study the usefulness of preoperative IGB-BIB® &quot;grA&quot; [sleeve resection (SR) or gastric
      bypass (GB)] to help decrease postsurgical complications. Secondly we try to check the rate
      of IGB-BIB® failures (a total weight loss less than 10% of the initial weight), and the
      impact on decreasing hospital stay and rate of surgical reoperations. METHODS: The study was
      a clinical prospective and randomized essay coming from 2009. Cases (grA) had an IGB during 6
      months before surgery vs Controls (grB)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postsurgical Morbidity on Both Arms of the Study</measure>
    <time_frame>within the 90 days after surgery</time_frame>
    <description>postsurgical morbidity includes all kind of post operative morbidity( mild ,moderate and severe) moderate and severe post surgical morbidity is the most important one</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Postsurgical Morbidity</measure>
    <time_frame>during the 6 months having the intragastric balloon and 90 days after surgery</time_frame>
    <description>total postsurgical morbidity included the morbidity specifically due to the Intragastric balloon plus all the postoperative morbidity related to the surgical procedure severe intragastric balloon morbidity refers only to medical complications which meet the criteria of severe of &quot;The accordion severity grading system &quot;.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital Stay,</measure>
    <time_frame>the period of the study started when patients were randomizated and finished 90 days after surgery</time_frame>
    <description>all in all hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Surgical Conversion to Open Surgery</measure>
    <time_frame>during the initial laparoscopic surgery</time_frame>
    <description>number of patients with surgical conversion from laparoscopic to open surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Re-operations</measure>
    <time_frame>during all the period of the study ending within 90 days after surgery</time_frame>
    <description>Percentage of Re-operations during all the period of the study ending within 90 days after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">81</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>IGB group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the intervention in the group A : was to place a preoperative intragastric balloon (IGB-BIB®) in the stomach for 6 months before surgery plus an hypocaloric diet 1200 Kilocalories (Kcal)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>the intervention in this control group B was the specified diet (a hypocaloric diet of 1200 Kilocalories (Kcal)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intragastric Balloon (IGB), group A</intervention_name>
    <description>the intervention was to place An intragastric balloon (BIOENTERICS INTRAGASTRIC BALLOON (BIB) SYSTEM) endoscopically under conscious sedation and was kept in the stomach during minimum 6 months. Patients were also treated with proton bomb inhibitors (PPI), and prokinetics to control gastroesophageal reflux . The balloon was endoscopically removed with the patient under general anesthesia to avoid bronco-aspiration related problems</description>
    <arm_group_label>IGB group A</arm_group_label>
    <other_name>BIOENTERICS INTRAGASTRIC BALLOON (BIB) SYSTEM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diet, control group B</intervention_name>
    <description>the intervention in this cotrol group B was only 1200 Kilocalories (Kcal) diet</description>
    <arm_group_label>IGB group A</arm_group_label>
    <arm_group_label>control group B</arm_group_label>
    <other_name>1200 Kilocalories (Kcal) diet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. - Morbid obesity (BMI ≥ 40 kg/m2 ) with a failed Conventional Medical treatment

          2. - Morbid obesity (BMI ≥ 35 kg/m2) with important comorbidity with a failed
             Conventional Medical treatment

          3. - they should be operated by a laparoscopic gastric sleeve or by laparoscopic gastric
             by-pass

        Exclusion Criteria:

          1. - Slight adherence to previous medical treatments .

          2. - Hiatal hernia more than 3 cms

          3. - Patients with active gastric or duodenal ulcer disease

          4. - Severe esophagitis

          5. - Psychiatric diseases (depression, bulimia etc)

          6. - Associated Severe Systemic Disease not amenable to improve with weight loss

          7. - Patients with Inflammatory bowel diseases

          8. - Patients on anticoagulant treatment or steroids .

          9. - Addiction to Drugs or alcohol

         10. - Past history of gastric surgery ,antireflux surgery or any other type of bariatric
             surgery

         11. - Patient refusing to be followed 6 months before and after surgery

         12. - Pregnancy or foreseeable pregnancy during the study

         13. - Patients with gastric or esophageal varices

         14. - proton pump inhibitor (PPI) allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis R Rábago, MD,PhD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Gastroenterology Department ,Severo Ochoa Hospital</name>
      <address>
        <city>Leganés</city>
        <state>Madrid</state>
        <zip>28911</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Hodson RM, Zacharoulis D, Goutzamani E, Slee P, Wood S, Wedgwood KR. Management of obesity with the new intragastric balloon. Obes Surg. 2001 Jun;11(3):327-9.</citation>
    <PMID>11433910</PMID>
  </reference>
  <reference>
    <citation>Loffredo A, Cappuccio M, De Luca M, de Werra C, Galloro G, Naddeo M, Forestieri P. Three years experience with the new intragastric balloon, and a preoperative test for success with restrictive surgery. Obes Surg. 2001 Jun;11(3):330-3.</citation>
    <PMID>11433911</PMID>
  </reference>
  <reference>
    <citation>Doldi SB, Micheletto G, Perrini MN, Librenti MC, Rella S. Treatment of morbid obesity with intragastric balloon in association with diet. Obes Surg. 2002 Aug;12(4):583-7.</citation>
    <PMID>12194556</PMID>
  </reference>
  <reference>
    <citation>Busetto L, Segato G, De Luca M, Bortolozzi E, MacCari T, Magon A, Inelmen EM, Favretti F, Enzi G. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study. Obes Surg. 2004 May;14(5):671-6.</citation>
    <PMID>15186637</PMID>
  </reference>
  <reference>
    <citation>Sallet JA, Marchesini JB, Paiva DS, Komoto K, Pizani CE, Ribeiro ML, Miguel P, Ferraz AM, Sallet PC. Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004 Aug;14(7):991-8.</citation>
    <PMID>15329191</PMID>
  </reference>
  <reference>
    <citation>Alfalah H, Philippe B, Ghazal F, Jany T, Arnalsteen L, Romon M, Pattou F. Intragastric balloon for preoperative weight reduction in candidates for laparoscopic gastric bypass with massive obesity. Obes Surg. 2006 Feb;16(2):147-50.</citation>
    <PMID>16469215</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>November 19, 2013</study_first_submitted>
  <study_first_submitted_qc>November 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2013</study_first_posted>
  <results_first_submitted>April 13, 2017</results_first_submitted>
  <results_first_submitted_qc>March 11, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 10, 2019</results_first_posted>
  <last_update_submitted>March 11, 2019</last_update_submitted>
  <last_update_submitted_qc>March 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Severo Ochoa</investigator_affiliation>
    <investigator_full_name>luis ramon rábago torre</investigator_full_name>
    <investigator_title>Dr. Phd Luis Ramon Rábago Torre</investigator_title>
  </responsible_party>
  <keyword>morbid obesity</keyword>
  <keyword>bioenterics intragastric balloon</keyword>
  <keyword>bariatric surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>151 patients were eligibles for the study and were evaluated at the endocrinologist office</recruitment_details>
      <pre_assignment_details>40 patients rejected to be included in the study and 30 were excluded before randomization for not to fulfill all the established requirement to be included</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Group B</title>
          <description>42 patients control group : patients were followed during at least 6 months before surgery by the same group of nutritionist that followed the group A and with the same type of diet and diet recommendations</description>
        </group>
        <group group_id="P2">
          <title>IGB-BIB® Group A</title>
          <description>39 patients included have a preoperative intragastric balloon during a period of 6 months before operation
preoperative intragastric balloon ( IGB-BIB®): An intragastric balloon (BIOENTERICS INTRAGASTRIC BALLOON (BIB) SYSTEM)is placed endoscopically under conscious sedation was kept in the stomach during minimum 6 months. Patients were also treated with proton bomb inhibitors, and prokinetics to control gastroesophageal reflux . The balloon was endoscopically removed with the patient under general anesthesia to avoid bronco-aspiration related problems</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group B</title>
          <description>this is the control group, It includes patients followed during at least 6 months before bariatric surgery by the same group of nutritionist that followed the group A and with the same type of diet and diet recommendations</description>
        </group>
        <group group_id="B2">
          <title>Intragastrc Balloon (IGB) Group A</title>
          <description>this is the intervention group, it includes patients who had a preoperative intragastric balloon during a period of 6 months before operation
preoperative intragastric balloon ( IGB-BIB®): An intragastric balloon (BIOENTERICS INTRAGASTRIC BALLOON (BIB) SYSTEM)is placed endoscopically under conscious sedation was kept in the stomach during minimum 6 months. Patients were also treated with proton bomb inhibitors, and prokinetics to control gastroesophageal reflux . The balloon was endoscopically removed with the patient under general anesthesia to avoid bronco-aspiration related problems</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="34"/>
            <count group_id="B2" value="32"/>
            <count group_id="B3" value="66"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years OF AGE</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.6" spread="9.2"/>
                    <measurement group_id="B2" value="43" spread="10.2"/>
                    <measurement group_id="B3" value="42.8" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Spain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Americam Society of Anestesiologist Physical Status Classification System (ASA) ; ASA score III;</title>
          <description>Physical Status Classification System (ASA) ASA classification scores patients ranging from I - V ; ASA I A normal healthy patient Healthy, ASA II A patient with mild systemic disease ASA III A patient with severe systemic disease ASA IV A patient with severe systemic disease that is a constant threat to life ASA V A moribund patient who is not expected to survive without the operation E , ASA VI A declared brain-dead patient whose organs are being removed for donor purposes .WE MEASURE THE NUMBER of participants IN EACH GROUP classified as ASA III</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Starting weight (kg)</title>
          <description>the starting weight is expressed in Kg</description>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125" spread="18.5"/>
                    <measurement group_id="B2" value="129.2" spread="19.4"/>
                    <measurement group_id="B3" value="127.1" spread="18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Starting body mass index (starting BMI)</title>
          <description>Starting body mass index (starting BMI) is expressed in kg/m^2</description>
          <units>&quot;kg/m^2&quot;</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46" spread="4.9"/>
                    <measurement group_id="B2" value="46.4" spread="6.9"/>
                    <measurement group_id="B3" value="46.2" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Starting body mass index (starting BMI) &gt; 50 (&quot;kg/m^2&quot;)</title>
          <description>number of patientes with a Starting body mass index (starting BMI) &gt; 50 &quot;kg/m^2&quot;</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total weight loss (TWL)</title>
          <description>Total weight loss (TWL) is expressed in Kg</description>
          <units>Kg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3" lower_limit="1" upper_limit="6.5"/>
                    <measurement group_id="B2" value="16" lower_limit="8.2" upper_limit="22.7"/>
                    <measurement group_id="B3" value="7" lower_limit="3" upper_limit="17.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight before surgery (Kg)</title>
          <description>Weight before surgery is expressed in KG</description>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="121.3" spread="20.5"/>
                    <measurement group_id="B2" value="112.8" spread="16.4"/>
                    <measurement group_id="B3" value="117.2" spread="19.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI before surgery(&quot;kg/m^2&quot;)</title>
          <units>&quot;kg/m^2&quot;</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.3" spread="5.5"/>
                    <measurement group_id="B2" value="40" spread="6.2"/>
                    <measurement group_id="B3" value="42.2" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Excess weight loss (EWL) before surgery</title>
          <description>Excess weight loss (EWL) before surgery is expressed as a percentage %</description>
          <population>missing data</population>
          <units>percentage of EWL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="64"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.54" lower_limit="1.4" upper_limit="10.07"/>
                    <measurement group_id="B2" value="27.14" lower_limit="12.2" upper_limit="35.2"/>
                    <measurement group_id="B3" value="11.1" lower_limit="3.4" upper_limit="28.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Excess Body Mass Index Loss (EBMIL) before surgery (excess BMI loss)</title>
          <units>percentage of EBMI loss</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="B2" value="6.04" lower_limit="3.9" upper_limit="7.9"/>
                    <measurement group_id="B3" value="3" lower_limit="1" upper_limit="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgery (sleeve resection (LSG)or gastric bypass (LGBP)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>LSG</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>LGBP</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>total body weight loss (TBWL) &gt; 10%</title>
          <population>missing data</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="64"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Percentage of Failure of Intragastric Balloon</title>
          <description>It was considered that intragastric balloon failed when a total weight loss = or &gt; than 10% of the starting weight has NOT been achieved.
The total number of patients with IGB balloon was 41 in this essay, but 9 were excluded post randomization of the final analysis because they were not finally operated.
The percentage of IGB balloon failure was calculated for all the patients had intragastric balloon</description>
          <population>this variable is not applicable to group B</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Operation time (hours)</title>
          <description>Operation time is expressed in hours</description>
          <population>missing data</population>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="64"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.8" spread="0.73"/>
                    <measurement group_id="B2" value="2.8" spread="0.79"/>
                    <measurement group_id="B3" value="2.8" spread="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ICU (hours) intensive care unit</title>
          <description>time spent in the intensive care unit is expressed in ICU (hours)</description>
          <population>missing data</population>
          <units>hours)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="33"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="65"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.5" lower_limit="7.2" upper_limit="23"/>
                    <measurement group_id="B2" value="11" lower_limit="8" upper_limit="24"/>
                    <measurement group_id="B3" value="20" lower_limit="8" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Postsurgical Morbidity on Both Arms of the Study</title>
        <description>postsurgical morbidity includes all kind of post operative morbidity( mild ,moderate and severe) moderate and severe post surgical morbidity is the most important one</description>
        <time_frame>within the 90 days after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group B</title>
            <description>this is the control group, It includes patients followed during at least 6 months before bariatric surgery by the same group of nutritionist that followed the group A and with the same type of diet and diet recommendations</description>
          </group>
          <group group_id="O2">
            <title>IGB Group A</title>
            <description>this is the intervention group, it includes patients who had a preoperative intragastric balloon during a period of 6 months before operation
preoperative intragastric balloon ( IGB-BIB®): An intragastric balloon (BIOENTERICS INTRAGASTRIC BALLOON (BIB) SYSTEM)is placed endoscopically under conscious sedation was kept in the stomach during minimum 6 months. Patients were also treated with proton bomb inhibitors, and prokinetics to control gastroesophageal reflux . The balloon was endoscopically removed with the patient under general anesthesia to avoid bronco-aspiration related problems</description>
          </group>
        </group_list>
        <measure>
          <title>Postsurgical Morbidity on Both Arms of the Study</title>
          <description>postsurgical morbidity includes all kind of post operative morbidity( mild ,moderate and severe) moderate and severe post surgical morbidity is the most important one</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>postsurgical morbidity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>moderate-severe postsurgical morbidity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.689</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.53</ci_lower_limit>
            <ci_upper_limit>2.60</ci_upper_limit>
            <estimate_desc>risk ratio (RR)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Postsurgical Morbidity</title>
        <description>total postsurgical morbidity included the morbidity specifically due to the Intragastric balloon plus all the postoperative morbidity related to the surgical procedure severe intragastric balloon morbidity refers only to medical complications which meet the criteria of severe of &quot;The accordion severity grading system &quot;.</description>
        <time_frame>during the 6 months having the intragastric balloon and 90 days after surgery</time_frame>
        <population>Group B did not receive an intra-gastric balloon, and was thus not evaluated for balloon related complications.</population>
        <group_list>
          <group group_id="O1">
            <title>Group B</title>
            <description>34 patients control group : patients were followed during at least 6 months before surgery by the same group of nutritionist that followed the group A and with the same type of diet and diet recommendations</description>
          </group>
          <group group_id="O2">
            <title>IGB Group A</title>
            <description>32 patients included have a preoperative intragastric balloon during a period of 6 months before operation
preoperative intragastric balloon ( IGB-BIB®): An intragastric balloon (BIOENTERICS INTRAGASTRIC BALLOON (BIB) SYSTEM)is placed endoscopically under conscious sedation was kept in the stomach during minimum 6 months. Patients were also treated with proton bomb inhibitors, and prokinetics to control gastroesophageal reflux . The balloon was endoscopically removed with the patient under general anesthesia to avoid bronco-aspiration related problems</description>
          </group>
        </group_list>
        <measure>
          <title>Total Postsurgical Morbidity</title>
          <description>total postsurgical morbidity included the morbidity specifically due to the Intragastric balloon plus all the postoperative morbidity related to the surgical procedure severe intragastric balloon morbidity refers only to medical complications which meet the criteria of severe of &quot;The accordion severity grading system &quot;.</description>
          <population>Group B did not receive an intra-gastric balloon, and was thus not evaluated for balloon related complications.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>intragastric balloon morbidity (complications)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>severe intragastric balloon morbidity</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>total postsurgical morbidity</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="34"/>
                    <count group_id="O2" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.144</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.59</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.84</ci_lower_limit>
            <ci_upper_limit>3.01</ci_upper_limit>
            <estimate_desc>all in all balloon and postsurgical morbidity in group A vs. group B.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Stay,</title>
        <description>all in all hospital stay</description>
        <time_frame>the period of the study started when patients were randomizated and finished 90 days after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group B</title>
            <description>this is the control group, It includes patients followed during at least 6 months before bariatric surgery by the same group of nutritionist that followed the group A and with the same type of diet and diet recommendations</description>
          </group>
          <group group_id="O2">
            <title>IGB Group A</title>
            <description>this is the intervention group, it includes patients who had a preoperative intragastric balloon during a period of 6 months before operation
preoperative intragastric balloon ( IGB-BIB®): An intragastric balloon (BIOENTERICS INTRAGASTRIC BALLOON (BIB) SYSTEM)is placed endoscopically under conscious sedation was kept in the stomach during minimum 6 months. Patients were also treated with proton bomb inhibitors, and prokinetics to control gastroesophageal reflux . The balloon was endoscopically removed with the patient under general anesthesia to avoid bronco-aspiration related problems</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Stay,</title>
          <description>all in all hospital stay</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.3" spread="15.3"/>
                    <measurement group_id="O2" value="7" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.937</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Surgical Conversion to Open Surgery</title>
        <description>number of patients with surgical conversion from laparoscopic to open surgery</description>
        <time_frame>during the initial laparoscopic surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group B</title>
            <description>this is the control group, It includes patients followed during at least 6 months before bariatric surgery by the same group of nutritionist that followed the group A and with the same type of diet and diet recommendations</description>
          </group>
          <group group_id="O2">
            <title>IGB Group A</title>
            <description>this is the intervention group, it includes patients who had a preoperative intragastric balloon during a period of 6 months before operation
preoperative intragastric balloon ( IGB-BIB®): An intragastric balloon (BIOENTERICS INTRAGASTRIC BALLOON (BIB) SYSTEM)is placed endoscopically under conscious sedation was kept in the stomach during minimum 6 months. Patients were also treated with proton bomb inhibitors, and prokinetics to control gastroesophageal reflux . The balloon was endoscopically removed with the patient under general anesthesia to avoid bronco-aspiration related problems</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Surgical Conversion to Open Surgery</title>
          <description>number of patients with surgical conversion from laparoscopic to open surgery</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Re-operations</title>
        <description>Percentage of Re-operations during all the period of the study ending within 90 days after surgery</description>
        <time_frame>during all the period of the study ending within 90 days after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group B</title>
            <description>this is the control group, It includes patients followed during at least 6 months before bariatric surgery by the same group of nutritionist that followed the group A and with the same type of diet and diet recommendations</description>
          </group>
          <group group_id="O2">
            <title>IGB Group A</title>
            <description>this is the intervention group, it includes patients who had a preoperative intragastric balloon during a period of 6 months before operation
preoperative intragastric balloon ( IGB-BIB®): An intragastric balloon (BIOENTERICS INTRAGASTRIC BALLOON (BIB) SYSTEM)is placed endoscopically under conscious sedation was kept in the stomach during minimum 6 months. Patients were also treated with proton bomb inhibitors, and prokinetics to control gastroesophageal reflux . The balloon was endoscopically removed with the patient under general anesthesia to avoid bronco-aspiration related problems</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Re-operations</title>
          <description>Percentage of Re-operations during all the period of the study ending within 90 days after surgery</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.8"/>
                    <measurement group_id="O2" value="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.673</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>from randomization six months before surgery to 90 days after surgey</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Group B</title>
          <description>34 patients control group : patients were followed during at least 6 months before surgery by the same group of nutritionist that followed the group A and with the same type of diet and diet recommendations</description>
        </group>
        <group group_id="E2">
          <title>IGB Group A</title>
          <description>32 patients included have a preoperative intragastric balloon during a period of 6 months before operation
preoperative intragastric balloon ( IGB-BIB®): An intragastric balloon (BIOENTERICS INTRAGASTRIC BALLOON (BIB) SYSTEM)is placed endoscopically under conscious sedation was kept in the stomach during minimum 6 months. Patients were also treated with proton bomb inhibitors, and prokinetics to control gastroesophageal reflux . The balloon was endoscopically removed with the patient under general anesthesia to avoid bronco-aspiration related problems</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>acute renal failure</sub_title>
                <description>peritonitis, sepsis, suture dehiscence, respiratory failure, eventration intraperitoneal postoperative bleeding</description>
                <counts group_id="E1" events="8" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>surgical wound infection</sub_title>
                <description>mild surgical wound infection ,mild respiratory failure ,eventration, intra abdominal abscess, urinary tract infection, bleeding, haematoma,pneumonia</description>
                <counts group_id="E1" events="15" subjects_affected="8" subjects_at_risk="34"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>we could not reach the number of scheduled patients in the study, due to the number of postrandomization excluded patients; the number of superobese is too short in order to get conclusion in this small group of patients</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Luis Ramon Rabago Torre</name_or_title>
      <organization>Hospital severo ochoa</organization>
      <phone>34914818000 ext 8326</phone>
      <email>lrabagot@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

